Alexandra Mancini
2022
In 2022, Alexandra Mancini earned a total compensation of $290.5K as Senior Vice President, Clinical & Regulatory Affairs at InMed Pharmaceuticals, a 28% decrease compared to previous year.
Compensation breakdown
Option Awards | $29,456 |
---|---|
Salary | $261,027 |
Total | $290,483 |
Mancini received $261K in salary, accounting for 90% of the total pay in 2022.
Mancini also received $29.5K in option awards.
Rankings
In 2022, Alexandra Mancini's compensation ranked 5,122nd out of 5,756 executives tracked by ExecPay. In other words, Mancini earned more than 11.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,122 | 11th |
Manufacturing | 2,813 | 10th |
Chemicals And Allied Products | 1,308 | 8th |
Drugs | 1,229 | 7th |
Pharmaceutical Preparations | 897 | 7th |
Mancini's colleagues
We found four more compensation records of executives who worked with Alexandra Mancini at InMed Pharmaceuticals in 2022.
News
InMed Pharmaceuticals CEO Eric Adams' 2024 pay rises 13% to $415K
October 28, 2024
InMed Pharmaceuticals CEO Eric Adams' 2023 pay falls 22% to $368K
October 27, 2023
InMed Pharmaceuticals CEO Eric Adams' 2022 pay falls 36% to $468K
October 28, 2022
InMed Pharmaceuticals CEO Eric Adams' 2021 pay jumps 73% to $735K
October 28, 2021